About Tillotts Pharma
Based on our expertise, we strive to offer gastrointestinal (GI) healthcare professionals innovative treatment solutions that can improve patients’ well-being and quality of life. We are engaged in advancing care and are continuing to build a well-balanced portfolio of products for the digestive system through our own development activities, collaborations with third parties and acquisitions. By combining our energetic and dynamic approach with our in-depth knowledge of the digestive system, we are committed to making a difference for the millions of people worldwide who suffer from GI-diseases.
Facts about Tillotts Pharma
Facts about Tillotts Pharma
- Focus : Manufacturer
- Industry : Pharma
Here you will find Tillotts Pharma AG
Last viewed contents
Allon enrolling patients in pivotal davunetide Phase 2/3 trial
Alcon and Amgen Sign Collaboration Agreement to Develop and Commercialize Innovative Therapies in Ophthalmology
Cornell researcher wins prestigious award for research on viruses that kill cancer cells
Genzyme Board Unanimously Rejects Sanofi-Aventis Tender Offer
Amoxicillin
American Society of Gene & Cell Therapy - Milwaukee, USA
MOLOGEN AG Interim Financial Report: Clinical cancer studies are progressing according to plan - Phase II/III of colorectal cancer study with MGN1703 have also begun in Russia
